Summary

● From a short-term investment perspective, the company presents a deteriorated fundamental situation

● The company's Refinitiv ESG score, based on a ranking of the company relative to its industry, comes out particularly well.


Strengths

● The company is in a robust financial situation considering its net cash and margin position.

● Analysts covering this company mostly recommend stock overweighting or purchase.

● The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.

● Historically, the company has been releasing figures that are above expectations.


Weaknesses

● The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 160.87 times its estimated earnings per share for the ongoing year.

● The company appears highly valued given the size of its balance sheet.

● The valuation of the company is particularly high given the cash flows generated by its activity.

● For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.

● For the last four months, the sales outlook for the coming years has been revised downwards. No recovery of the group's activities is yet foreseen.

● For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.

● For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.

● Over the past four months, analysts' average price target has been revised downwards significantly.

● The overall consensus opinion of analysts has deteriorated sharply over the past four months.

● Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.

● The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.